196x Filetype DOCX File size 0.31 MB Source: namsa.com
SAMPLE SUBMISSION FORM www.namsa.com Instructions: Electronically complete a single form for each set or batch of samples submitted using Microsoft Word. The form must be completed in its entirety to expedite the study initiation. Fields identified in bold must be completed before your order can be processed. Fields marked with * may appear on your final report. Upon completion, please print, sign and date the form at the bottom. Please include this form with your sample and ship to the NAMSA address that appears below. If you have any questions, please reach your usual contact at NAMSA or a Technical Advisor at +33 478 079 234 for France and +49 6022 50638 00 for Germany Sponsor Information Ship To (this address may be reported in the final report) Bill To ☐ Same as Ship To Information Company Name Company Name Contact Address Address City, State, Zip City, State, Zip Country Country Phone (Accounts Payable) Phone Details of the order E-mail Purchase Order Number Mobile Phone Proposal Number Test Article Characterization Definitions are available on our website: How to Address a Sample Submission Form / Guide de remplissage de la Fiche Information Produit *Name *Reference *Batch/Lot ID Type If Other, please describe: *Physical ☐ Illustrations or photos attached Description If not available, please provide a detailed description for characterization and identification of the test article (nature of material, shape of material, color, consistency, size, packaging, …): Intended Clinical ☐ IFU attached Use If IFU not available, please provide a detailed description : ☐ Sterile – ☐ Not Sterile ☐ Aseptically Prepared *Sterility ☐ NAMSA to Sterilize (Steam – Additional fee will apply) If Other, please describe: Stability testing is the responsibility of the sponsor and is subject to authorities audit *Stability Expiration date (Shelf life): Stability after Does the stability of the test article change upon opening? ☐ No (Not applicable) opening packaging ☐ Yes If yes, for how many hours, days, months is the test article stable upon opening: *Raw materials Contact to Patient? Contact surface Part name? (Name, CAS Number, Trade Name, % w/w) (direct, indirect or no area? (if applicable) contact) (if applicable) *Composition Please complete the 4 sections or provide a separate document with these information in a tabular format ☐ Separate document attached Shipping conditions Temperature sensitive ☐ No (uncontrolled conditions) ☐ Yes (please complete below) Sponsor’s responsibility : Temperature: If Other, describe: The Sponsor needs to establish Monitoring the conditions the test item is If Other, describe: expected to be subject to during system: transportation (appropriate Refrigerant: If Other, describe: vehicle, container …). Appropriate monitoring measures or special Light sensitive ☐ No ☐ Yes Describe special care: care is required if the test item is temperature, light and/or Humidity sensitive ☐ No ☐ Yes Describe special care: humidity sensitive. Other: Describe special care: Title: Sample submission form ID: E-QUA183 Status: Release Page 1 of 1 Revision: 7 Effective date: 30 Juil 2021 SAMPLE SUBMISSION FORM www.namsa.com Test article Reminder (will automatically be fulfilled before printing) Name Reference Batch/Lot ID: *Storage Conditions Protected from light ☐ No ☐ Yes Describe special care: at NAMSA Protected from ☐ No ☐ Yes Describe special care: Humidity Other: Describe special care: If liquid or gel Number (vials, syringes…): Quantity per mL container: Quantity of test If powder Number (vials, syringes…): Quantity per g article (s) submitted container: If solid Quantity (devices, Quantity per packages…): packaging: Test Article Preparation If applicable, instruction before use to assure If the test device is a gel, liquid, homogeneity: cream or powder, please indicate: Osmolality: pH: ☐ Needles are provided Need cleaning and/or disinfection ☐ No ☐ Yes, before use? describe: Need specific preparation or handling ☐ No ☐ Yes, before use? describe: Part (s) of the test article need to be ☐ No ☐ Yes, list: excluded? Can be Cut ☐ No ☐ Yes (cutting can expose inner surfaces – cutting will destroy the test article) Is an Absorbent? ☐ No ☐ Yes, describe: Is there any surface coating? ☐ No ☐ Yes, describe: Other Special Instructions Is the test article tested in its final product form and condition ☐ No ☐ Yes (packaging)? Test article Extraction Includes multiple components with ☐ No ☐ Yes (If yes, is advised to choose the ratio below based on the different thicknesses (> and < 0.5 thinnest material layer of that component) mm)? *Test Article Surface 2 *Extracts to be Prepared Area cm by When needed, NAMSA might adapt the ratio (Total contact surface area) *Test Article Weight g *Extraction Conditions Cytotoxicity: Other Tests: (the highest temperature that will If Other, please describe: not degrade the test article is Other conditions to be justified. The extraction time If Other, please describe: recommended) may be less than 24h but no less than 4h Other conditions to be justified Other Information Countries/Regions that test ☐ USA ☐ China ☐ Other: data will be submitted to ☐ Europe ☐ Japan ☐ Not known *Disposal For test article to be Other: Account #: returned Special handling instructions: Mandatory for liquid, gel, powder, paste, cream and/or if the test article is a Pharmaceutical or Biologic Safety Data Title: Sample submission form ID: E-QUA183 Status: Release Page 2 of 2 Revision: 7 Effective date: 30 Juil 2021 SAMPLE SUBMISSION FORM www.namsa.com Test article Reminder (will automatically be fulfilled before printing) Name Reference Batch/Lot ID: Nature of the test article's contact Surface device External communicating device Implant device ☐ Male ☐ Female Population ☐ Adults ☐ Children ☐ Neonates Minimum weight if specified: Contact duration If < 4h, Please specify contact duration: If > 30 days Clinical exposure per patientMaximum number of test article that could be used in a patient**: Dose Based Threshold (DBT) µg/day (For chemical analysis only) ** If more than one, please describe the exposure scenario (for example: “two devices will be implanted at the same time”; “a new device will be implanted every three years”; “a patient may use the re-usable device daily, up to four treatments/day, 10 minutes/treatment”; etc.) Please print this form and sign. Signature must be handwritten. By this signature, the Sponsor assures the exactitude of the information listed above. Sponsor Function: Date: Signature: Title: Sample submission form ID: E-QUA183 Status: Release Page 3 of 2 Revision: 7 Effective date: 30 Juil 2021 SAMPLE SUBMISSION FORM www.namsa.com Shipping Information Please, include a signed copy of this form and ship to the facility as designated below. Thank you for your business. Germany Facility: France Facility: Chemical Analysis In Vitro Toxicology Chemical Characterization In Vivo Toxicology In Vivo Efficacy and Functional Antimicrobial and Microbiology Specials Microbiology (Bioburden, Sterility, LAL) Histology NAMSA Laboratory Services GmbH NAMSA Attention: Samples reception Attention: Samples reception Industrie Center Obernburg 115 Chemin de l’Islon 63784 Obernburg 38670 Chasse sur Rhône Germany France Documentation Required Please, include these documents attached with this form. Information for Use (IFU) Illustrations or photos of the device If applicable : Safety Data Title: Sample submission form ID: E-QUA183 Status: Release Revision: 7 Effective date: 30 Juil 2021
no reviews yet
Please Login to review.